Amgen’s AMGN stock has risen almost 16% in a month. A lot of this price increase is due to strong third-quarter 2025 results, ...

Today, Benzinga's options scanner spotted 9 options trades for Amgen. This is not a typical pattern. The sentiment among these major traders is split, with 55% bullish and 22% bearish. Among all the ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Amgen Inc. (NASDAQ:AMGN) ranks among the Best Low Volatility Investments in December 2025. Goldman Sachs reaffirmed its $400 ...

Amgen (AMGN) shares soared 3.5% in the last trading session to close at $285.41. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more ...

Amgen Inc. (NASDAQ:AMGN) is one of the best drug stocks to buy right now. Amgen Inc. (NASDAQ:AMGN) reported its fiscal Q2 2025 earnings on August 5, with total revenues increasing 9% to $9.2 billion ...

In addition to Scotiabank, Amgen also received a Buy from Piper Sandler’s David Amsellem in a report issued yesterday. However, on the same day, Truist Financial maintained a Hold rating on Amgen ...

Though Amgen AMGN and Viking Therapeutics VKTX do not currently market any obesity drugs, they are among the few biotechs that have shown immense potential in this space. Amgen boasts a strong ...